Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP808878.RAy_s6sAOWRKMy4QHEU_mH0cjxTzYr-9wWd84YfCJGRSE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP808878.RAy_s6sAOWRKMy4QHEU_mH0cjxTzYr-9wWd84YfCJGRSE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP808878.RAy_s6sAOWRKMy4QHEU_mH0cjxTzYr-9wWd84YfCJGRSE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP808878.RAy_s6sAOWRKMy4QHEU_mH0cjxTzYr-9wWd84YfCJGRSE130_provenance.
- befree-20150227 importedOn "2015-02-27" NP808878.RAy_s6sAOWRKMy4QHEU_mH0cjxTzYr-9wWd84YfCJGRSE130_provenance.
- NP808878.RAy_s6sAOWRKMy4QHEU_mH0cjxTzYr-9wWd84YfCJGRSE130_assertion wasGeneratedBy ECO_0000203 NP808878.RAy_s6sAOWRKMy4QHEU_mH0cjxTzYr-9wWd84YfCJGRSE130_provenance.
- NP808878.RAy_s6sAOWRKMy4QHEU_mH0cjxTzYr-9wWd84YfCJGRSE130_assertion wasDerivedFrom befree-20150227 NP808878.RAy_s6sAOWRKMy4QHEU_mH0cjxTzYr-9wWd84YfCJGRSE130_provenance.
- NP808878.RAy_s6sAOWRKMy4QHEU_mH0cjxTzYr-9wWd84YfCJGRSE130_assertion SIO_000772 21703428 NP808878.RAy_s6sAOWRKMy4QHEU_mH0cjxTzYr-9wWd84YfCJGRSE130_provenance.
- NP808878.RAy_s6sAOWRKMy4QHEU_mH0cjxTzYr-9wWd84YfCJGRSE130_assertion evidence source_evidence_literature NP808878.RAy_s6sAOWRKMy4QHEU_mH0cjxTzYr-9wWd84YfCJGRSE130_provenance.
- NP808878.RAy_s6sAOWRKMy4QHEU_mH0cjxTzYr-9wWd84YfCJGRSE130_assertion description "[Comparable in efficacy with Bevacizumab, monotherapy with the PAR1 i3 loop pepducin P1pal-7 provided significant 75% inhibition of lung tumor growth in nude mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP808878.RAy_s6sAOWRKMy4QHEU_mH0cjxTzYr-9wWd84YfCJGRSE130_provenance.